G9a-Mediated Regulation of OXT and AVP Expression in the Basolateral Amygdala Mediates Stress-Induced Lasting Behavioral Depression and Its Reversal by Exercise

Molecular Neurobiology

Volumn 53, Issue 5, 2016, Pages 2843-2856

  Kim, Tae Kyung ^a   Lee, Jung Eun ^a   Kim, Ji Eun ^a   Park, Jin Young ^a   Choi, Juli ^a   Kim, Hannah ^a   Lee, Eun Hwa ^a   Han, Pyung Lim ^a  

^a Ewha Womans University   (South Korea)

Author keywords

BLA; Depression; Dimethylation; Exercise; G9a; Oxytocin; Vasopressin

Indexed keywords

ARGIPRESSIN; HISTONE H3; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE G9A; HORMONE RECEPTOR STIMULATING AGENT; OXYTOCIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WAY 267464; G9A PROTEIN, MOUSE; HISTONE LYSINE METHYLTRANSFERASE; OXYTOCIN RECEPTOR; VASOPRESSIN RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; DEPRESSION; DOWN REGULATION; EXERCISE; GENE EXPRESSION; GENOMICS; HORMONAL REGULATION; MALE; MICROARRAY ANALYSIS; MOUSE; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; STRESS; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; COMPLICATION; GENETIC TRANSCRIPTION; GENETICS; MENTAL STRESS; METABOLISM; PATHOLOGY;

ANIMALS; ARGININE VASOPRESSIN; BASOLATERAL NUCLEAR COMPLEX; BEHAVIOR, ANIMAL; DEPRESSION; HISTONE-LYSINE N-METHYLTRANSFERASE; MALE; MICE, INBRED C57BL; OXYTOCIN; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; RNA, SMALL INTERFERING; STRESS, PSYCHOLOGICAL; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84927553896     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9160-z     Document Type: Article

References (55)

1. Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161–1169
2. Strohle A (2009) Physical activity, exercise, depression and anxiety disorders. J Neural Transm 116:777–784
3. Krogh J, Nordentoft M, Sterne JA, Lawlor DA (2011) The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 72:529–538
4. Josefsson T, Lindwall M, Archer T (2014) Physical exercise intervention in depressive disorders: meta-analysis and systematic review. Scand J Med Sci Sports 24:259–272
5. Mammen G, Faulkner G (2013) Physical activity and the prevention of depression: a systematic review of prospective studies. Am J Prev Med 45:649–657
6. Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629–683
7. Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A (2012) Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev 92:1813–1864
8. Arletti R, Bertolini A (1987) Oxytocin acts as an antidepressant in two animal models of depression. Life Sci 41:1725–1730
9. Yan Y, Wang YL, Su Z, Zhang Y, Guo SX, Liu AJ, Wang CH, Sun FJ et al (2014) Effect of oxytocin on the behavioral activity in the behavioral despair depression rat model. Neuropeptides 48:83–89
10. Winslow JT, Insel TR (2002) The social deficits of the oxytocin knockout mouse. Neuropeptides 36:221–229
11. Lee HJ, Caldwell HK, Macbeth AH, Tolu SG, Young WS 3rd (2008) A conditional knockout mouse line of the oxytocin receptor. Endocrinology 149:3256–3263
12. Yang J, Pan YJ, Yin ZK, Hai GF, Lu L, Zhao Y, Wang DX, Wang H et al (2012) Effect of arginine vasopressin on the behavioral activity in the behavior despair depression rat model. Neuropeptides 46:141–149
13. van Londen L, Goekoop JG, van Kempen GM, Frankhuijzen-Sierevogel AC, Wiegant VM, van der Velde EA, De Wied D (1997) Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 17:284–292
14. Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P (2002) Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci U S A 99:6370–6375
15. Mlynarik M, Zelena D, Bagdy G, Makara GB, Jezova D (2007) Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horm Behav 51:395–405
16. Caldwell HK, Wersinger SR, Young WS 3rd (2008) The role of the vasopressin 1b receptor in aggression and other social behaviours. Prog Brain Res 170:65–72
17. Neumann ID, Landgraf R (2012) Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 35:649–659
18. Tsankova N, Renthal W, Kumar A, Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355–367
19. Vialou V, Feng J, Robison AJ, Nestler EJ (2013) Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Toxicol 53:59–87
20. Zhang X, Wen H, Shi X (2012) Lysine methylation: beyond histones. Acta Biochim Biophys Sin 44:14–27
21. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N et al (2002) G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes 16:1779–1791
22. Covington HE 3rd, Maze I, Sun H, Bomze HM, DeMaio KD, Wu EY, Dietz DM, Lobo MK et al (2011) A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron 71:656–670
23. Shinkai Y, Tachibana M (2011) H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 25:781–788
24. Krishnan V, Nestler EJ (2011) Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167:1305–1320
25. Murray EA, Wise SP, Drevets WC (2011) Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdala. Biol Psychiatry 69:e43–e54
26. Kim KS, Han PL (2009) Mice lacking adenylyl cyclase-5 cope badly with repeated restraint stress. J Neurosci Res 87:2983–2993
27. Greenwood BN, Strong PV, Loughridge AB, Day HE, Clark PJ, Mika A, Hellwinkel JE, Spence KG et al (2012) 5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise. PLoS ONE 7:e46118
28. Sah P, Faber ES, Lopez De Armentia M, Power J (2003) The amygdaloid complex: anatomy and physiology. Physiol Rev 83:803–834
29. Seo JS, Park JY, Choi J, Kim TK, Shin JH, Lee JK, Han PL (2012) NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J Neurosci 32:9690–9699
30. Park JY, Kim TK, Choi J, Lee JE, Kim H, Lee EH, Han PL (2014) Implementation of a two-dimensional behavior matrix to distinguish individuals with differential depression states in a rodent model of depression. Exp Neurobiol 23:215–223
31. Kim TK, Park JY, Han PL (2015) Physiological parameters in the blood of a murine stress-induced depression model before and after repeated passive exercise. Endocrinol Metab 30:e2
32. Kim KS, Lee KW, Baek IS, Lim CM, Krishnan V, Lee JK, Nestler EJ, Han PL (2008) Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J Neurochem 107:105–115
33. Lee KW, Kim JB, Seo JS, Kim TK, Im JY, Baek IS, Kim KS, Lee JK et al (2009) Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. J Neurochem 108:165–175
34. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15
35. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
36. Kuo MH, Allis CD (1999) In vivo cross-linking and immunoprecipitation for studying dynamic Protein: DNA associations in a chromatin environment. Methods 19:425–433
37. Chakrabarti SK, James JC, Mirmira RG (2002) Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J Biol Chem 277:13286–13293
38. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959
39. Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y (2008) G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J 27:2681–2690
40. Young WS 3rd, Gainer H (2003) Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors. Neuroendocrinology 78:185–203
41. Viviani D, Stoop R (2008) Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. Prog Brain Res 170:207–218
42. Sessoms-Sikes S, Honse Y, Lovinger DM, Colbran RJ (2005) CaMKIIalpha enhances the desensitization of NR2B-containing NMDA receptors by an autophosphorylation-dependent mechanism. Mol Cell Neurosci 29:139–147
43. Raveendran R, Devi Suma Priya S, Mayadevi M, Steephan M, Santhoshkumar TR, Cheriyan J, Sanalkumar R, Pradeep KK et al (2009) Phosphorylation status of the NR2B subunit of NMDA receptor regulates its interaction with calcium/calmodulin-dependent protein kinase II. J Neurochem 110:92–105
44. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR (1997) Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276:2042–2045
45. Peng S, Zhang Y, Zhang J, Wang H, Ren B (2010) ERK in learning and memory: a review of recent research. Int J Mol Sci 11:222–232
46. Carlezon WA Jr, Duman RS, Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28:436–445
47. Thomas MG, Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5:173–183
48. Davis S, Vanhoutte P, Pages C, Caboche J, Laroche S (2000) The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J Neurosci 20:4563–4572
49. Landgraf R, Neumann ID (2004) Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 25:150–176
50. Schaefer A, Sampath SC, Intrator A, Min A, Gertler TS, Surmeier DJ, Tarakhovsky A, Greengard P (2009) Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 64:678–691
51. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, Craighead WE, Baldewicz TT et al (2000) Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med 62:633–638
52. Erickson KI, Miller DL, Roecklein KA (2012) The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist 18:82–97
53. Danielsson L, Noras AM, Waern M, Carlsson J (2013) Exercise in the treatment of major depression: a systematic review grading the quality of evidence. Physiother Theory Pract 29:573–585
54. Kmietowicz Z (2013) Evidence that exercise helps in depression is still weak, finds review. BMJ 13:347
55. Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, McMurdo M, Mead GE (2013) Exercise for depression. Cochrane Database Syst Rev 12:9